Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/E17EF7A03131158EB88C481DC9D3CE75DD97FFB7C65DD1EE678F324A5E56B7E42C571D595FE73A06C38E03A68ED3E7ADhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E17EF7A03131158EB88C481DC9D3CE75DD97FFB7C65DD1EE678F324A5E56B7E42C571D595FE73A06C38E03A68ED3E7ADhttp://www.w3.org/2000/01/rdf-schema#comment"Inhibitory receptor KIR2DL1 in combination with HLA-C2 ligand confers susceptibility to chronic hepatitis B (CHB) whereas inhibitory receptor KIR2DL3 or KIR2DL3 homozygote in the presence of HLA-C1C1 genotype shows protection against CHB; Observational study of gene-disease association. (HuGE Navigator)"xsd:string
http://purl.uniprot.org/uniprot/#_901EEE58FA298FE1F4EFBEBA5DED972A44005205F6230D1B95D434D2E2233AB4943E512AFE916151ABD151D4EB7BCE9Bhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/E17EF7A03131158EB88C481DC9D3CE75DD97FFB7C65DD1EE678F324A5E56B7E42C571D595FE73A06C38E03A68ED3E7AD
http://purl.uniprot.org/uniprot/F6IQR8http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/E17EF7A03131158EB88C481DC9D3CE75DD97FFB7C65DD1EE678F324A5E56B7E42C571D595FE73A06C38E03A68ED3E7AD
http://purl.uniprot.org/uniprot/#_F6IQR8-mappedCitation-20643584http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/E17EF7A03131158EB88C481DC9D3CE75DD97FFB7C65DD1EE678F324A5E56B7E42C571D595FE73A06C38E03A68ED3E7AD